Gestational diabetes mellitus (GDM) manifests as different degrees of carbohydrate intolerance during pregnancy. According to several studies, GDM affects 4% to 25% of pregnant women. The majority of patients with GDM have varying levels of insulin resistance and chronic low-grade inflammation, which are related to vascular injury and dysfunction and subsequent platelet activation.^\[[@R1]\]^ Consequently, platelet activation may be closely related to GDM severity. The mean platelet volume (MPV) is one of the indexes used to evaluate platelet morphology and activity. An elevated MPV has been demonstrated to be related to cardiovascular diseases and other conditions, such as hypertension and nonalcoholic fatty liver disease.^\[[@R2]\]^ To our knowledge, few studies have demonstrated the relationship between the MPV and GDM. We aimed to evaluate the diagnostic value of the MPV for GDM in the first trimester.

This research was conducted at the Department of Obstetrics and Gynecology in Peking University International Hospital between December 2014 and June 2019. As a retrospective study and data analysis was performed anonymously, this study was exempt from the ethical approval and informed consent from patients. We collected retrospectively the medical records of 1550 women with GDM, and 2103 subjects with healthy pregnancies were assigned to the control group. For all the pregnant women, routine blood counts and other necessary tests were performed using venous blood collected at the first prenatal visit after fasting for at least 8 h. All women returned to the clinic between 24 and 28 weeks of gestation for their oral glucose tolerance tests (75 g glucose) to diagnose GDM. The statistical analysis in our study was performed with Python (3.7.4, Guido van Rossum, the Netherlands) and R (3.5.1, University of Auckland, New Zealand). Logistic regression was used to assess the association between the GDM outcome and the MPV. Receiver-operating characteristic (ROC) curve analysis was performed to determine the MPV cutoff value to predict GDM in the early stage of pregnancy.

The histogram of the MPV frequency for patients with GDM was normally distributed, with a 95% confidence interval (CI) of 10.17 to 10.26. In terms of the histogram of the frequency of MPV for non-GDM cases, the data were normally distributed with a 95% CI of 10.24 to 10.32 \[Table [1](#T1){ref-type="table"}\]. The results of the logistic regression analyses for GDM showed that increasing MPV values were associated with a favorable outcome, namely, non-GDM (odds ratio = 0.92, 95% CI: \[0.86--0.99\], *P* = 0.0222). The ROC analysis showed that the MPV cutoff value was 10.25 fL, with 57.1% sensitivity and 47.2% specificity in this study. The AUC value was 0.522 \[Supplementary Figure 1\].
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This study demonstrated that increasing MPV values were associated with a favorable outcome, namely, non-GDM. The result of the ROC analysis indicated that the MPV may have a certain relationship with GDM, but the MPV value alone cannot be a diagnostic predicator of GDM.

Unique endocrinological changes occur during the entire pregnancy period. Insulin resistance is increased three- to four-fold after 13 weeks. In fact, patients with GDM are also predisposed to long-term complications. GDM can increase the risks for type 2 diabetes mellitus and cardiovascular diseases. Furthermore, the rates of some diseases, such as obesity, hypertension, and metabolic syndrome, are significantly increased among women with a GDM history. Consequently, it is necessary to launch multiple scientific studies of tools for predicting the occurrence of GDM. Increased platelet activity and high MPVs have been reported in patients with diabetes mellitus. The relationship between the MPV and severity of diabetes mellitus has also been indicated. The mechanism underlying the MPV of women with GDM has not been explained scientifically. Nevertheless, there are some plausible explanations for this relationship. Insulin resistance may induce platelet activation, which can be assessed by means of the MPV measurement. The key pathophysiological aspects of platelet activation, including hyperglycemia, glycemic variability, insulin resistance, and inflammation, have been reported.^\[[@R3]\]^ Several studies have suggested that the MPV might be an indicator of chronic inflammatory status in GDM.

Several studies were launched to determine whether the MPV in the first trimester could be used as a predicator to assess the GDM status during pregnancy. However, different studies have yielded inconsistent conclusions. Colak *et al*^\[[@R4]\]^ found that the MPV can be a useful predictor of GDM in early pregnancy. The cutoff value for MPV was 7.38 fL, with a sensitivity and specificity of 70% and 60%, respectively. A meta-analysis^\[[@R5]\]^ indicated that MPV was significantly increased in patients with GDM in the third trimester, while the difference did not appear in the second trimester. It is coincident with the highest insulin resistance in the third trimester. These results suggest that there may be varying levels of MPV in different trimester during pregnancy period. The underlying mechanism maybe the insulin resistance and inflammation.

The early diagnosis of pre-pregnancy or gestational diabetes can significantly improve the prognosis of the mother and child. Additionally, several studies have examined predictors of GDM. The predicators in these studies are increased levels of fasting glucose; hemoglobin A1C; inflammatory markers, such as C-reactive protein and tumor necrosis factor-alpha; and other novel biomarkers, such as glycosylated fibronectin and soluble prorenin receptor.

There are several limitations in the study. First, the number of cases was limited. Second, a close follow-up of the maternal and fetal outcomes according to the MPV values in the third trimester should be performed in future studies. Third, it would be better to compare MPV values in different trimesters. Further studies are required in the future.

In view of the adverse complications of GDM in mothers and their children, we are committed to more scientific research of methods for an earlier and a more accurate diagnosis of pre-gestational diabetes mellitus or GDM to contribute to improving the health of women and their children.
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